Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: fda + triaminic + patch  Related to the article below (Last Update: 8/5/2008)

Pharmalot FDA strengthens policy on vetting of advisers San Francisco Chronicle,  USA - Appointments to the powerful committees, whose recommendations are usually followed by the FDA, have come under fire in recent years as Congress and ... FDA advisers must abide by new financial limits The Associated Press FDA Puts $50000 Cap on Conflicts in Advisory Hearings Wall Street Journal Blogs FDA to weed out conflict of interest in advisory committees Medical Marketing and Media Bloomberg - The Hill all 132 news articles » Chatter Shmatter FDA OKs Medicines Co.'s Cleviprex (Update) TheStreet.com - Investors -- unaware of the drug's PDUFDA date, or goal date for an FDA decision -- have been waiting to hear about Cleviprex. The Medicine's Co revealed in ... FDA approves Medicines Co.'s blood-pressure drug CNNMoney.com UPDATE 1-Medicines Co gets FDA nod for blood pressure drug Reuters FDA Approves New Blood Pressure Drug From Medicines Co Chatter Shmatter Therapeutics Daily (subscription) (press release) - NJBIZ all 36 news articles »  MDCO TheMedGuru Tomato Growers Seeing Red Washington Post, United States - The growers knew the agency hadn't gotten to the source of the problem after the FDA told people to stop eating tomatoes and the illnesses increased, ... Actavis Totowa Finally Does The Right Thing US Recall News (press release) Maker of Defective Digitek Recalls All Generic Drugs Made at New ... Newsinferno.com Actavis Totowa LLC recalls generic drugs United Press International TheMedGuru - US Recall News (press release) all 157 news articles » ChattahBox With FDA Gaining Power Over Tobacco, They Can Protect Kids dBTechno, MA - Washington (dbTechno) - Just last week, the US House of Representatives voted in favor of passing a bill, granting the US Food and Drug Administration (FDA) ... US House Approves FDA to Regulate Tobacco HealthNews Editorial: Need to regulate nation's top killer Waco Tribune Herald Comment by M. Cass Wheeler Chief Executive Officer,American Heart Association Greenville News - Seattle Times all 557 news articles » FDA Reviewing Biomoda Submission for Cancer Screening Study MarketWatch - "Approval by the FDA of the study design this year allows us to move forward quickly to prove the efficacy of the assay. Approval by the Agency of the ...OTC:BMOD dBTechno Connecticut AG: Sunscreen Makers' Claims 'Misleading' Environment News Service - Aug 4, 2008 But almost a year later, the FDA has not implemented this rule change, prompting a frustrated Blumenthal to urge that the rules take effect in a letter last ... Sunscreen Labels Leave Consumers In The Dark InjuryBoard.com Senators prod FDA to raise standards on sunscreen CNNMoney.com Regulations Long Overdue On Sunscreen Hartford Courant CBS News - News Line 365 all 254 news articles » Ontario Now POZEN Receives Initial FDA Response To PA32540 SPA FOXBusiness - Aug 2, 2008 The company plans to meet with the FDA to discuss their responses to our proposed protocol for the Phase 3 pivotal studies, including the ... US Congress slams FDA for off-label promotion control failures Pharma Times (subscription) Trials and Medications RedOrbit Drug Company Executive Says FDA Too Overwhelmed to Ensure Safety ABC News guardian.co.uk - Los Angeles Times all 222 news articles »  AMGN - POZN - JNJ India's Aurobindo Pharma gets US FDA final approval for generic ... Forbes, NY - 35 minutes ago MUMBAI (Thomson Financial) - India's Aurobindo Pharma Ltd. said it received final approval from the United States Food and Drug Administration to make and ...PINK:AUBPF - BOM:524804 - MRK Toxic Drugs, Toxic System: Sociologist Predicts Drug Disasters Science Daily (press release) - 5, 2008) ? Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the ... HealthNewsDigest.com FDA 101: Dietary Supplements HealthNewsDigest.com, NY - By FDA (HealthNewsDigest.com) - The law defines dietary supplements in part as products taken by mouth that contain a "dietary ingredient. ... Merck?s Manufacturing Problems at Gardasil Factory May be Easing ... Newsinferno.com all 2 news articles »

FDA Warns Consumers Not to Use Triaminic Vapor Patch
Possible Safety and Health Risks to Children

The U.S. Food and Drug Administration (FDA) today is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children. Novartis Consumer Health also announced today that it is conducting a nationwide voluntary recall of all Triaminic Vapor Patch products.

FDA is advising consumers who have used the product and have concerns or questions to contact their physician or health care practitioner. In addition, the company is advising consumers to either discard or return the product to their point of purchase for a refund.

Triaminic Vapor Patch contains camphor, eucalyptus oil, and menthol. The reported side effects from swallowing or chewing on products containing camphor or eucalyptus oils vary from minor symptoms, such as a burning sensation in the mouth, headache, nausea and vomiting, to more severe and life-threatening reactions, such as seizures.

Article continues below and (thank you)

Triaminic Vapor Patch is labeled as a cough suppressant for children two (2) years of age and older. The directions on the label indicate the patch is to be applied to the throat or chest to allow the vapors to reach the nose and mouth. Multiple patches can be applied at one time. Once applied, the patch would be within close reach for a child to remove and place the product in his/her mouth. The Vapor Patch is a topical cough product applied externally and is not for oral consumption.

The product is sold over the counter at pharmacies and retail outlets nationwide.

Any adverse reactions experienced with the use of this product, and/or quality problems should be reported to the FDA's MedWatch Adverse Event Reporting program online at www.fda.gov/MedWatch/report.htm, by phone (1-800-FDA-1088), or by returning the postage-paid FDA form 3500, which may be downloaded from www.fda.gov/MedWatch/getforms.htm, by mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or fax (1-800-FDA-0178).